Search results for:
brentuximab vedotin
brentuximab vedotin
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Brentuximab Vedotin |
POWDER FOR INJECTION, INTRAVENOUS |
50 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Aug. 23, 2023
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Inpatient use is restricted to pediatric patients who meet one of the following criteria:
Use for all other indications is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Management of Chemotherapeutic or Hazardous Intravenous Extravasations Formulary Fact Sheet
Med Center
UNC Medical Center Formulary Restrictions